Full Text View
Tabular View
No Study Results Posted
Related Studies
hOKT3gamma1 (Ala-Ala) for the Treatment of Psoriatic Arthritis (PART)
This study has been suspended.
( FDA Clinical Hold )
Study NCT00239720   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: October 13, 2005   Last Updated: May 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arthritis, Psoriatic
Additional conditions recognized in this trial
Arthritis
More general conditions related to this trial
Bone Diseases
Joint Diseases
Musculoskeletal Diseases
Psoriasis
Skin Diseases
Skin Diseases, Papulosquamous
Spinal Diseases
Spondylarthritis
Spondylarthropathies
Interventions listed in this trial
hOKT3gamma1(Ala-Ala)
Placebo
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services